Clinical Trial Update: A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic Hyponatremia [Phase 3]

View source ↗

Summary

A Phase 3 study of intravenous conivaptan (Vaprisol) in pediatric patients with euvolemic or hypervolemic hyponatremia was terminated, with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• Vaprisol (Conivaptan)

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Hyponatremia | Phase 3 | Status: TERMINATED | Results posted: 2016-03-01